| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 397 | 2024 | 6915 | 13.190 |
Why?
|
| Psychotic Disorders | 201 | 2024 | 3193 | 9.520 |
Why?
|
| Schizophrenic Psychology | 128 | 2020 | 1646 | 7.290 |
Why?
|
| Diseases in Twins | 56 | 2015 | 447 | 5.580 |
Why?
|
| Genetic Predisposition to Disease | 137 | 2023 | 17790 | 2.870 |
Why?
|
| Schizotypal Personality Disorder | 24 | 2016 | 290 | 2.830 |
Why?
|
| Family | 74 | 2020 | 3189 | 2.700 |
Why?
|
| Bipolar Disorder | 99 | 2019 | 5078 | 2.680 |
Why?
|
| Neuropsychological Tests | 111 | 2024 | 7021 | 2.350 |
Why?
|
| Psychiatric Status Rating Scales | 115 | 2021 | 6015 | 2.240 |
Why?
|
| Genetic Linkage | 39 | 2011 | 2381 | 2.040 |
Why?
|
| Cognition Disorders | 44 | 2023 | 3976 | 1.910 |
Why?
|
| Twins, Dizygotic | 34 | 2018 | 236 | 1.910 |
Why?
|
| Twins | 28 | 2016 | 339 | 1.880 |
Why?
|
| Family Health | 30 | 2021 | 1257 | 1.870 |
Why?
|
| Twins, Monozygotic | 40 | 2018 | 469 | 1.810 |
Why?
|
| Affective Disorders, Psychotic | 17 | 2016 | 186 | 1.680 |
Why?
|
| Endophenotypes | 22 | 2023 | 255 | 1.640 |
Why?
|
| Social Adjustment | 21 | 2020 | 632 | 1.590 |
Why?
|
| Social Environment | 30 | 2011 | 1022 | 1.520 |
Why?
|
| Longitudinal Studies | 114 | 2024 | 14495 | 1.420 |
Why?
|
| Mental Disorders | 59 | 2021 | 6796 | 1.380 |
Why?
|
| Memory, Short-Term | 23 | 2020 | 978 | 1.360 |
Why?
|
| Alcoholism | 44 | 2011 | 1961 | 1.340 |
Why?
|
| Verbal Learning | 13 | 2014 | 462 | 1.250 |
Why?
|
| Adult | 435 | 2024 | 219994 | 1.220 |
Why?
|
| Male | 547 | 2024 | 359744 | 1.190 |
Why?
|
| Humans | 794 | 2024 | 760621 | 1.170 |
Why?
|
| Tobacco Use Disorder | 12 | 2015 | 700 | 1.160 |
Why?
|
| Antisocial Personality Disorder | 19 | 2008 | 224 | 1.140 |
Why?
|
| Adolescent | 243 | 2024 | 87810 | 1.130 |
Why?
|
| Mood Disorders | 18 | 2020 | 1124 | 1.120 |
Why?
|
| Polymorphism, Genetic | 14 | 2010 | 4291 | 1.090 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 21 | 2020 | 1988 | 1.070 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 28 | 2021 | 3701 | 1.060 |
Why?
|
| Depressive Disorder | 50 | 2010 | 3726 | 1.050 |
Why?
|
| Receptors, Dopamine D2 | 6 | 2015 | 485 | 1.010 |
Why?
|
| Conduct Disorder | 6 | 2007 | 245 | 1.000 |
Why?
|
| Polymorphism, Single Nucleotide | 40 | 2023 | 15789 | 0.980 |
Why?
|
| Substance-Related Disorders | 34 | 2022 | 4371 | 0.980 |
Why?
|
| Marijuana Abuse | 12 | 2017 | 411 | 0.970 |
Why?
|
| Veterans | 30 | 2014 | 2642 | 0.950 |
Why?
|
| Risk | 73 | 2024 | 9631 | 0.950 |
Why?
|
| Cerebral Cortex | 27 | 2022 | 5761 | 0.940 |
Why?
|
| Brain | 56 | 2023 | 26951 | 0.930 |
Why?
|
| Antipsychotic Agents | 24 | 2022 | 3061 | 0.920 |
Why?
|
| Female | 454 | 2024 | 391270 | 0.920 |
Why?
|
| Chromosome Mapping | 20 | 2009 | 4625 | 0.910 |
Why?
|
| Prefrontal Cortex | 19 | 2016 | 2212 | 0.900 |
Why?
|
| Depressive Disorder, Major | 16 | 2023 | 4744 | 0.900 |
Why?
|
| Sex Characteristics | 19 | 2024 | 2629 | 0.890 |
Why?
|
| Heroin Dependence | 4 | 2008 | 172 | 0.840 |
Why?
|
| Stress Disorders, Post-Traumatic | 19 | 2017 | 4555 | 0.840 |
Why?
|
| Memory Disorders | 12 | 2013 | 1197 | 0.830 |
Why?
|
| Anxiety Disorders | 26 | 2021 | 2714 | 0.820 |
Why?
|
| Intelligence | 11 | 2016 | 921 | 0.820 |
Why?
|
| Thinking | 4 | 2015 | 319 | 0.800 |
Why?
|
| Genetic Markers | 21 | 2017 | 2608 | 0.800 |
Why?
|
| Magnetic Resonance Imaging | 76 | 2023 | 36290 | 0.790 |
Why?
|
| Combat Disorders | 9 | 2014 | 301 | 0.780 |
Why?
|
| Hippocampus | 18 | 2023 | 3738 | 0.780 |
Why?
|
| Genotype | 53 | 2023 | 12960 | 0.770 |
Why?
|
| Risk Factors | 143 | 2023 | 74359 | 0.760 |
Why?
|
| Attention | 23 | 2024 | 2387 | 0.760 |
Why?
|
| Case-Control Studies | 73 | 2022 | 22053 | 0.760 |
Why?
|
| Middle Aged | 282 | 2021 | 220352 | 0.750 |
Why?
|
| Young Adult | 129 | 2024 | 58741 | 0.750 |
Why?
|
| Environment | 22 | 2016 | 1118 | 0.740 |
Why?
|
| Mental Recall | 13 | 2019 | 1206 | 0.720 |
Why?
|
| North America | 25 | 2023 | 1284 | 0.720 |
Why?
|
| Models, Genetic | 31 | 2017 | 3442 | 0.720 |
Why?
|
| Twin Studies as Topic | 11 | 2011 | 104 | 0.710 |
Why?
|
| Evoked Potentials, Auditory | 8 | 2022 | 529 | 0.700 |
Why?
|
| Chromosomes, Human, Pair 22 | 6 | 2008 | 346 | 0.700 |
Why?
|
| Alleles | 22 | 2022 | 6898 | 0.690 |
Why?
|
| Selenium-Binding Proteins | 3 | 2009 | 18 | 0.680 |
Why?
|
| Brain Mapping | 32 | 2016 | 6568 | 0.660 |
Why?
|
| Systems Analysis | 1 | 2020 | 169 | 0.660 |
Why?
|
| Taiwan | 22 | 2019 | 505 | 0.660 |
Why?
|
| Genome-Wide Association Study | 23 | 2023 | 12626 | 0.660 |
Why?
|
| Personality Assessment | 9 | 2010 | 650 | 0.660 |
Why?
|
| Disease Progression | 34 | 2024 | 13502 | 0.650 |
Why?
|
| Smoking | 15 | 2015 | 9073 | 0.650 |
Why?
|
| Phenotype | 59 | 2023 | 16546 | 0.630 |
Why?
|
| Age of Onset | 24 | 2019 | 3301 | 0.630 |
Why?
|
| Vietnam Conflict | 11 | 2014 | 100 | 0.630 |
Why?
|
| Amphetamine-Related Disorders | 3 | 2010 | 77 | 0.620 |
Why?
|
| Hydrocortisone | 8 | 2023 | 1803 | 0.610 |
Why?
|
| Risperidone | 3 | 2012 | 379 | 0.600 |
Why?
|
| Gene Expression Profiling | 16 | 2023 | 9411 | 0.600 |
Why?
|
| Panic Disorder | 6 | 2011 | 613 | 0.590 |
Why?
|
| Comorbidity | 43 | 2018 | 10551 | 0.590 |
Why?
|
| Thalamus | 6 | 2016 | 1041 | 0.580 |
Why?
|
| Spirituality | 3 | 2008 | 428 | 0.570 |
Why?
|
| Nerve Tissue Proteins | 4 | 2019 | 4407 | 0.560 |
Why?
|
| Sex Factors | 53 | 2023 | 10547 | 0.560 |
Why?
|
| Child Behavior Disorders | 6 | 2010 | 805 | 0.560 |
Why?
|
| Gene Frequency | 20 | 2015 | 3615 | 0.550 |
Why?
|
| Gambling | 4 | 2001 | 258 | 0.550 |
Why?
|
| Social Perception | 5 | 2018 | 431 | 0.550 |
Why?
|
| Blood Cells | 2 | 2011 | 305 | 0.540 |
Why?
|
| Lod Score | 14 | 2013 | 602 | 0.540 |
Why?
|
| Gene Expression | 13 | 2016 | 7588 | 0.530 |
Why?
|
| Multicenter Studies as Topic | 9 | 2020 | 1722 | 0.510 |
Why?
|
| Interview, Psychological | 14 | 2017 | 810 | 0.510 |
Why?
|
| China | 14 | 2020 | 2339 | 0.500 |
Why?
|
| Catechol O-Methyltransferase | 3 | 2007 | 251 | 0.500 |
Why?
|
| Pedigree | 29 | 2021 | 4578 | 0.500 |
Why?
|
| Schizophrenia, Paranoid | 17 | 2006 | 102 | 0.500 |
Why?
|
| Temporal Lobe | 9 | 2015 | 1688 | 0.500 |
Why?
|
| Stress, Psychological | 13 | 2023 | 4446 | 0.490 |
Why?
|
| Chromosomes, Human, Pair 10 | 4 | 2011 | 276 | 0.490 |
Why?
|
| Bullying | 6 | 2022 | 221 | 0.490 |
Why?
|
| Military Personnel | 9 | 2015 | 1244 | 0.480 |
Why?
|
| Functional Laterality | 12 | 2015 | 2253 | 0.480 |
Why?
|
| Acoustic Stimulation | 13 | 2022 | 1232 | 0.470 |
Why?
|
| Models, Psychological | 13 | 2019 | 827 | 0.470 |
Why?
|
| Genetic Heterogeneity | 4 | 2008 | 724 | 0.460 |
Why?
|
| Frontal Lobe | 11 | 2011 | 1420 | 0.460 |
Why?
|
| Siblings | 14 | 2020 | 824 | 0.460 |
Why?
|
| Birth Injuries | 3 | 2000 | 150 | 0.460 |
Why?
|
| Auditory Perception | 6 | 2019 | 580 | 0.460 |
Why?
|
| Haplotypes | 10 | 2016 | 2764 | 0.460 |
Why?
|
| Child | 101 | 2023 | 79806 | 0.460 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 240 | 0.450 |
Why?
|
| Depression | 22 | 2020 | 8044 | 0.450 |
Why?
|
| Genetic Association Studies | 11 | 2021 | 2717 | 0.450 |
Why?
|
| Registries | 33 | 2010 | 8469 | 0.440 |
Why?
|
| Linkage Disequilibrium | 12 | 2013 | 1996 | 0.440 |
Why?
|
| Child of Impaired Parents | 8 | 2013 | 459 | 0.440 |
Why?
|
| Odds Ratio | 28 | 2018 | 9716 | 0.440 |
Why?
|
| Delusions | 14 | 2020 | 298 | 0.430 |
Why?
|
| Nuclear Family | 11 | 2014 | 313 | 0.420 |
Why?
|
| Verbal Behavior | 4 | 2008 | 335 | 0.410 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2011 | 599 | 0.410 |
Why?
|
| Amygdala | 6 | 2016 | 1351 | 0.400 |
Why?
|
| Prevalence | 31 | 2017 | 15687 | 0.400 |
Why?
|
| Adoption | 8 | 2002 | 97 | 0.400 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2012 | 3775 | 0.400 |
Why?
|
| Vietnam | 11 | 2011 | 411 | 0.390 |
Why?
|
| Marijuana Smoking | 3 | 2015 | 257 | 0.390 |
Why?
|
| Electroencephalography | 15 | 2022 | 6189 | 0.390 |
Why?
|
| Hallucinations | 12 | 2017 | 366 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 15 | 6 | 2004 | 362 | 0.380 |
Why?
|
| Age Factors | 45 | 2023 | 18416 | 0.380 |
Why?
|
| Event-Related Potentials, P300 | 3 | 2019 | 149 | 0.380 |
Why?
|
| Receptors, Opioid, mu | 2 | 2015 | 166 | 0.380 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 2020 | 700 | 0.380 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 611 | 0.370 |
Why?
|
| Psychotropic Drugs | 7 | 2013 | 883 | 0.370 |
Why?
|
| Methamphetamine | 2 | 2010 | 162 | 0.370 |
Why?
|
| Neuroleptic Malignant Syndrome | 2 | 2007 | 74 | 0.370 |
Why?
|
| Cognition | 19 | 2023 | 6957 | 0.370 |
Why?
|
| Emotions | 9 | 2019 | 2734 | 0.370 |
Why?
|
| Personality Inventory | 8 | 2012 | 1018 | 0.360 |
Why?
|
| Alternative Splicing | 3 | 2015 | 1091 | 0.350 |
Why?
|
| Organ Size | 13 | 2023 | 2254 | 0.350 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 2 | 1 | 2009 | 7 | 0.350 |
Why?
|
| Personality Disorders | 11 | 2006 | 721 | 0.350 |
Why?
|
| Leukocytes | 4 | 2017 | 2026 | 0.350 |
Why?
|
| Pregnancy Complications | 8 | 2014 | 2942 | 0.340 |
Why?
|
| Genetic Variation | 6 | 2017 | 6551 | 0.340 |
Why?
|
| Prenatal Exposure Delayed Effects | 9 | 2019 | 2496 | 0.340 |
Why?
|
| Chromosomes, Human | 4 | 2008 | 442 | 0.340 |
Why?
|
| Image Processing, Computer-Assisted | 22 | 2019 | 8950 | 0.340 |
Why?
|
| Follow-Up Studies | 72 | 2024 | 39261 | 0.340 |
Why?
|
| Suicide | 12 | 2007 | 1599 | 0.340 |
Why?
|
| Affective Symptoms | 12 | 2011 | 416 | 0.340 |
Why?
|
| Cohort Studies | 47 | 2022 | 41335 | 0.330 |
Why?
|
| CLOCK Proteins | 1 | 2009 | 86 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 9 | 4 | 2006 | 534 | 0.330 |
Why?
|
| Transients and Migrants | 2 | 2022 | 162 | 0.320 |
Why?
|
| Membrane Transport Proteins | 2 | 2005 | 1035 | 0.320 |
Why?
|
| Parahippocampal Gyrus | 2 | 2014 | 115 | 0.320 |
Why?
|
| Psychometrics | 21 | 2015 | 3051 | 0.310 |
Why?
|
| D-Amino-Acid Oxidase | 3 | 2016 | 26 | 0.310 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2008 | 94 | 0.310 |
Why?
|
| Genomics | 12 | 2023 | 5794 | 0.310 |
Why?
|
| Reproducibility of Results | 30 | 2021 | 20080 | 0.310 |
Why?
|
| Minisatellite Repeats | 3 | 2005 | 164 | 0.300 |
Why?
|
| Theory of Mind | 3 | 2018 | 91 | 0.300 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2007 | 36 | 0.300 |
Why?
|
| Reference Values | 16 | 2016 | 4925 | 0.300 |
Why?
|
| Memory | 12 | 2020 | 2179 | 0.300 |
Why?
|
| Analysis of Variance | 20 | 2017 | 6238 | 0.300 |
Why?
|
| National Institute of Mental Health (U.S.) | 3 | 2005 | 105 | 0.300 |
Why?
|
| Limbic System | 5 | 2019 | 419 | 0.290 |
Why?
|
| Morbidity | 5 | 2020 | 1765 | 0.290 |
Why?
|
| Genes, erbB | 1 | 2007 | 5 | 0.290 |
Why?
|
| Social Values | 1 | 2008 | 225 | 0.290 |
Why?
|
| Mothers | 5 | 2019 | 2186 | 0.290 |
Why?
|
| Psychomotor Disorders | 2 | 2015 | 149 | 0.290 |
Why?
|
| Psychoses, Substance-Induced | 6 | 2015 | 99 | 0.290 |
Why?
|
| Schizophrenic Language | 3 | 2006 | 57 | 0.280 |
Why?
|
| Social Behavior Disorders | 3 | 2017 | 96 | 0.280 |
Why?
|
| Severity of Illness Index | 25 | 2019 | 15840 | 0.280 |
Why?
|
| Ganglionic Stimulants | 2 | 2005 | 18 | 0.280 |
Why?
|
| Multifactorial Inheritance | 8 | 2023 | 1365 | 0.280 |
Why?
|
| Factor Analysis, Statistical | 9 | 2015 | 998 | 0.280 |
Why?
|
| Hypothalamus | 2 | 2015 | 998 | 0.270 |
Why?
|
| Life Change Events | 8 | 2017 | 952 | 0.270 |
Why?
|
| Computational Biology | 3 | 2017 | 3505 | 0.270 |
Why?
|
| Religion and Psychology | 1 | 2008 | 178 | 0.270 |
Why?
|
| Paternal Age | 3 | 2019 | 87 | 0.270 |
Why?
|
| Cocaine-Related Disorders | 3 | 2005 | 460 | 0.260 |
Why?
|
| Apolipoproteins | 1 | 2008 | 320 | 0.260 |
Why?
|
| Agoraphobia | 2 | 2004 | 177 | 0.260 |
Why?
|
| Genome, Human | 8 | 2011 | 4417 | 0.260 |
Why?
|
| Auditory Cortex | 2 | 2020 | 362 | 0.260 |
Why?
|
| Terminology as Topic | 8 | 2003 | 1535 | 0.260 |
Why?
|
| Pattern Recognition, Visual | 3 | 2011 | 810 | 0.260 |
Why?
|
| Role | 3 | 2024 | 177 | 0.260 |
Why?
|
| Neural Inhibition | 3 | 2017 | 589 | 0.260 |
Why?
|
| Lipoproteins, HDL | 3 | 2013 | 667 | 0.260 |
Why?
|
| Predictive Value of Tests | 17 | 2019 | 15289 | 0.260 |
Why?
|
| Receptors, Cell Surface | 3 | 2005 | 2825 | 0.260 |
Why?
|
| DNA Methylation | 4 | 2016 | 4373 | 0.250 |
Why?
|
| Cerebral Ventricles | 4 | 2017 | 542 | 0.250 |
Why?
|
| Saccades | 3 | 2014 | 233 | 0.250 |
Why?
|
| Aged | 87 | 2021 | 169152 | 0.250 |
Why?
|
| Risk Assessment | 22 | 2022 | 24123 | 0.250 |
Why?
|
| Genes | 3 | 2012 | 1845 | 0.250 |
Why?
|
| Personality | 5 | 2012 | 552 | 0.240 |
Why?
|
| Paranoid Disorders | 7 | 2013 | 61 | 0.240 |
Why?
|
| Behavioral Symptoms | 2 | 2013 | 185 | 0.240 |
Why?
|
| Perinatology | 1 | 2004 | 62 | 0.240 |
Why?
|
| Cannabis | 3 | 2022 | 436 | 0.240 |
Why?
|
| Data Interpretation, Statistical | 6 | 2008 | 2696 | 0.240 |
Why?
|
| Evoked Potentials | 3 | 2022 | 1036 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2005 | 286 | 0.230 |
Why?
|
| Psychiatry | 5 | 2004 | 1689 | 0.230 |
Why?
|
| Intelligence Tests | 8 | 2015 | 500 | 0.230 |
Why?
|
| Semantics | 4 | 2006 | 599 | 0.230 |
Why?
|
| Bulimia | 2 | 2003 | 399 | 0.230 |
Why?
|
| Human Genome Project | 2 | 2003 | 199 | 0.230 |
Why?
|
| Alcohol-Related Disorders | 2 | 2015 | 235 | 0.230 |
Why?
|
| Pituitary-Adrenal System | 2 | 2020 | 552 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 6 | 7 | 2009 | 373 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 17 | 4 | 2008 | 419 | 0.230 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2004 | 64 | 0.230 |
Why?
|
| Nicotine | 3 | 2005 | 677 | 0.230 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 3707 | 0.230 |
Why?
|
| Homosexuality, Male | 2 | 2004 | 1273 | 0.230 |
Why?
|
| Cholinergic Antagonists | 2 | 2023 | 164 | 0.230 |
Why?
|
| Social Participation | 2 | 2023 | 183 | 0.230 |
Why?
|
| MicroRNAs | 2 | 2017 | 3790 | 0.230 |
Why?
|
| Wechsler Scales | 6 | 2016 | 257 | 0.230 |
Why?
|
| Disease Susceptibility | 9 | 2020 | 1791 | 0.230 |
Why?
|
| Statistics, Nonparametric | 8 | 2017 | 2852 | 0.220 |
Why?
|
| Receptors, Nicotinic | 3 | 2004 | 494 | 0.220 |
Why?
|
| Obsessive-Compulsive Disorder | 6 | 2018 | 1489 | 0.220 |
Why?
|
| Phonetics | 3 | 2006 | 198 | 0.220 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2003 | 43 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2005 | 452 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2019 | 246 | 0.220 |
Why?
|
| Early Diagnosis | 6 | 2016 | 1180 | 0.220 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 3758 | 0.220 |
Why?
|
| Amino Acid Substitution | 2 | 2007 | 1737 | 0.220 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2005 | 263 | 0.220 |
Why?
|
| Coitus | 1 | 2004 | 131 | 0.220 |
Why?
|
| Genetics, Medical | 4 | 2013 | 336 | 0.220 |
Why?
|
| Trinucleotide Repeats | 2 | 2005 | 257 | 0.220 |
Why?
|
| Genetic Counseling | 4 | 2001 | 624 | 0.220 |
Why?
|
| Inflammation | 3 | 2020 | 10756 | 0.220 |
Why?
|
| Confidence Intervals | 9 | 2010 | 2932 | 0.220 |
Why?
|
| Potassium Channels | 2 | 2019 | 534 | 0.210 |
Why?
|
| United States | 47 | 2021 | 72461 | 0.210 |
Why?
|
| Discrimination Learning | 2 | 1997 | 278 | 0.210 |
Why?
|
| Executive Function | 5 | 2017 | 1374 | 0.210 |
Why?
|
| Health Status | 3 | 2007 | 4081 | 0.210 |
Why?
|
| Developmental Disabilities | 4 | 2021 | 1504 | 0.210 |
Why?
|
| Self Concept | 6 | 2016 | 1039 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2005 | 4490 | 0.210 |
Why?
|
| Psychological Tests | 5 | 2016 | 639 | 0.210 |
Why?
|
| Enzymes | 1 | 2004 | 261 | 0.210 |
Why?
|
| Smell | 2 | 1997 | 259 | 0.210 |
Why?
|
| Resilience, Psychological | 3 | 2023 | 768 | 0.210 |
Why?
|
| Concept Formation | 3 | 1998 | 159 | 0.210 |
Why?
|
| Genetic Research | 3 | 2006 | 172 | 0.200 |
Why?
|
| Cluster Analysis | 5 | 2012 | 2698 | 0.200 |
Why?
|
| Interpersonal Relations | 5 | 2015 | 1428 | 0.200 |
Why?
|
| Psychomotor Performance | 9 | 2014 | 1878 | 0.200 |
Why?
|
| Point Mutation | 2 | 2005 | 1594 | 0.200 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2003 | 783 | 0.200 |
Why?
|
| Statistics as Topic | 11 | 2015 | 2362 | 0.200 |
Why?
|
| Personal Satisfaction | 3 | 2012 | 643 | 0.200 |
Why?
|
| Auditory Perceptual Disorders | 3 | 2017 | 36 | 0.200 |
Why?
|
| Fetal Diseases | 2 | 2014 | 911 | 0.200 |
Why?
|
| Alcohol Drinking | 7 | 2015 | 4013 | 0.190 |
Why?
|
| Volition | 2 | 1999 | 62 | 0.190 |
Why?
|
| Pregnancy | 26 | 2019 | 29749 | 0.190 |
Why?
|
| Obstetric Labor Complications | 4 | 2001 | 236 | 0.190 |
Why?
|
| Choroid Plexus | 1 | 2023 | 237 | 0.190 |
Why?
|
| Phobic Disorders | 2 | 2006 | 437 | 0.190 |
Why?
|
| Logistic Models | 18 | 2017 | 13314 | 0.180 |
Why?
|
| Manuals as Topic | 9 | 1988 | 99 | 0.180 |
Why?
|
| Dominance, Cerebral | 5 | 2006 | 622 | 0.180 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2005 | 829 | 0.180 |
Why?
|
| Wounds and Injuries | 2 | 2005 | 2477 | 0.180 |
Why?
|
| Fetal Hypoxia | 2 | 2000 | 30 | 0.180 |
Why?
|
| Child Abuse | 2 | 2020 | 1067 | 0.180 |
Why?
|
| Diagnosis, Differential | 25 | 2002 | 12965 | 0.180 |
Why?
|
| Anxiety | 9 | 2022 | 4538 | 0.180 |
Why?
|
| Microsatellite Repeats | 6 | 2010 | 786 | 0.180 |
Why?
|
| Self Mutilation | 1 | 2000 | 58 | 0.180 |
Why?
|
| Haloperidol | 5 | 1997 | 389 | 0.180 |
Why?
|
| Genome | 2 | 2008 | 1739 | 0.180 |
Why?
|
| Causality | 5 | 2015 | 1242 | 0.170 |
Why?
|
| Saliva | 4 | 2020 | 820 | 0.170 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2012 | 540 | 0.170 |
Why?
|
| Glycolysis | 1 | 2004 | 828 | 0.170 |
Why?
|
| Syndrome | 10 | 2019 | 3280 | 0.170 |
Why?
|
| Serine Endopeptidases | 1 | 2005 | 1021 | 0.170 |
Why?
|
| Probability | 9 | 2023 | 2475 | 0.170 |
Why?
|
| Nonverbal Communication | 1 | 1999 | 63 | 0.170 |
Why?
|
| Sexual Partners | 1 | 2004 | 753 | 0.170 |
Why?
|
| Genetics | 1 | 2000 | 114 | 0.170 |
Why?
|
| Cross-Sectional Studies | 17 | 2022 | 25942 | 0.170 |
Why?
|
| Family Characteristics | 6 | 2010 | 1001 | 0.160 |
Why?
|
| Iowa | 18 | 1996 | 103 | 0.160 |
Why?
|
| Reaction Time | 7 | 2019 | 2075 | 0.160 |
Why?
|
| Pilot Projects | 13 | 2014 | 8555 | 0.160 |
Why?
|
| Chi-Square Distribution | 7 | 2013 | 3465 | 0.160 |
Why?
|
| Mental Health | 5 | 2012 | 3213 | 0.160 |
Why?
|
| Minority Groups | 2 | 2023 | 1201 | 0.160 |
Why?
|
| Sulfotransferases | 1 | 2019 | 149 | 0.160 |
Why?
|
| Remission Induction | 2 | 2022 | 2392 | 0.160 |
Why?
|
| Social Behavior | 4 | 2017 | 1131 | 0.160 |
Why?
|
| Nortriptyline | 4 | 1986 | 79 | 0.160 |
Why?
|
| Clozapine | 3 | 2007 | 506 | 0.160 |
Why?
|
| Genetic Testing | 4 | 2016 | 3531 | 0.160 |
Why?
|
| Expressed Emotion | 2 | 2014 | 92 | 0.150 |
Why?
|
| Mental Processes | 2 | 2007 | 245 | 0.150 |
Why?
|
| Calcineurin | 2 | 2011 | 229 | 0.150 |
Why?
|
| Exons | 4 | 2019 | 2388 | 0.150 |
Why?
|
| Culture | 2 | 2015 | 622 | 0.150 |
Why?
|
| Principal Component Analysis | 4 | 2018 | 940 | 0.150 |
Why?
|
| Models, Statistical | 11 | 2016 | 5075 | 0.150 |
Why?
|
| Prognosis | 25 | 2022 | 29658 | 0.150 |
Why?
|
| Schizophrenia, Disorganized | 10 | 2006 | 10 | 0.150 |
Why?
|
| Epidemiology | 1 | 2000 | 278 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 3 | 2006 | 5785 | 0.150 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2018 | 952 | 0.150 |
Why?
|
| Political Systems | 1 | 1997 | 23 | 0.150 |
Why?
|
| War Crimes | 1 | 1997 | 22 | 0.150 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2019 | 2125 | 0.150 |
Why?
|
| Nerve Net | 6 | 2021 | 2261 | 0.150 |
Why?
|
| Prospective Studies | 24 | 2023 | 54303 | 0.150 |
Why?
|
| Association Learning | 1 | 2019 | 219 | 0.150 |
Why?
|
| Gyrus Cinguli | 3 | 2018 | 1114 | 0.150 |
Why?
|
| Brain Chemistry | 1 | 2001 | 959 | 0.150 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 388 | 0.150 |
Why?
|
| Educational Status | 6 | 2015 | 2515 | 0.140 |
Why?
|
| Child Psychiatry | 1 | 2000 | 226 | 0.140 |
Why?
|
| Suicidal Ideation | 2 | 2024 | 1425 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 2008 | 377 | 0.140 |
Why?
|
| Immune System Phenomena | 1 | 2016 | 17 | 0.140 |
Why?
|
| Psychophysiologic Disorders | 1 | 1999 | 221 | 0.140 |
Why?
|
| Suicide, Attempted | 8 | 2023 | 1378 | 0.140 |
Why?
|
| Central Nervous System Stimulants | 2 | 2003 | 1174 | 0.140 |
Why?
|
| Professional Misconduct | 1 | 1997 | 73 | 0.140 |
Why?
|
| Community Mental Health Centers | 1 | 1997 | 93 | 0.140 |
Why?
|
| Sibling Relations | 1 | 1996 | 46 | 0.140 |
Why?
|
| Multivariate Analysis | 11 | 2017 | 12159 | 0.140 |
Why?
|
| Vocabulary | 1 | 1997 | 165 | 0.140 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2018 | 2385 | 0.140 |
Why?
|
| Human Experimentation | 1 | 1997 | 123 | 0.140 |
Why?
|
| Sex Chromosome Aberrations | 5 | 1990 | 116 | 0.140 |
Why?
|
| Paroxetine | 1 | 1997 | 182 | 0.130 |
Why?
|
| Attitude to Health | 2 | 2004 | 2029 | 0.130 |
Why?
|
| Socioeconomic Factors | 11 | 2014 | 7806 | 0.130 |
Why?
|
| Space Perception | 2 | 2011 | 464 | 0.130 |
Why?
|
| Oxygen | 7 | 2014 | 4193 | 0.130 |
Why?
|
| Protein Isoforms | 2 | 2019 | 1697 | 0.130 |
Why?
|
| Olfaction Disorders | 1 | 2018 | 224 | 0.130 |
Why?
|
| Task Performance and Analysis | 5 | 2012 | 759 | 0.130 |
Why?
|
| Cerebellum | 2 | 2015 | 1496 | 0.130 |
Why?
|
| Corpus Callosum | 2 | 2021 | 749 | 0.130 |
Why?
|
| Ethics, Medical | 2 | 2001 | 783 | 0.130 |
Why?
|
| Virus Diseases | 3 | 2015 | 720 | 0.130 |
Why?
|
| Inheritance Patterns | 4 | 2016 | 340 | 0.130 |
Why?
|
| Tourette Syndrome | 2 | 1996 | 394 | 0.130 |
Why?
|
| Catatonia | 5 | 2013 | 178 | 0.130 |
Why?
|
| Histone Code | 1 | 2016 | 156 | 0.130 |
Why?
|
| Language Disorders | 2 | 2006 | 138 | 0.130 |
Why?
|
| Genetic Loci | 4 | 2023 | 2618 | 0.130 |
Why?
|
| Research Design | 15 | 2007 | 6180 | 0.130 |
Why?
|
| Anorexia Nervosa | 2 | 2008 | 1361 | 0.130 |
Why?
|
| Child, Preschool | 23 | 2021 | 42063 | 0.120 |
Why?
|
| Receptors, Dopamine D4 | 2 | 2008 | 170 | 0.120 |
Why?
|
| Aptitude | 1 | 1995 | 43 | 0.120 |
Why?
|
| Ubiquitin | 2 | 2010 | 838 | 0.120 |
Why?
|
| Patient Dropouts | 1 | 2017 | 412 | 0.120 |
Why?
|
| Facial Expression | 5 | 2018 | 508 | 0.120 |
Why?
|
| DNA Mutational Analysis | 5 | 2016 | 4107 | 0.120 |
Why?
|
| Regression Analysis | 9 | 2007 | 6360 | 0.120 |
Why?
|
| Infant, Low Birth Weight | 1 | 2000 | 859 | 0.120 |
Why?
|
| Epidemiologic Methods | 5 | 2000 | 1343 | 0.120 |
Why?
|
| Bulimia Nervosa | 2 | 2008 | 206 | 0.120 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2017 | 238 | 0.120 |
Why?
|
| Bacterial Infections | 2 | 2019 | 1403 | 0.120 |
Why?
|
| Genes, Recessive | 3 | 2015 | 626 | 0.120 |
Why?
|
| Gene Expression Regulation | 7 | 2016 | 11903 | 0.120 |
Why?
|
| Parents | 7 | 2020 | 3549 | 0.120 |
Why?
|
| Epidemiologic Research Design | 2 | 2015 | 368 | 0.120 |
Why?
|
| Behavior, Addictive | 1 | 2000 | 462 | 0.120 |
Why?
|
| Habituation, Psychophysiologic | 2 | 2013 | 147 | 0.120 |
Why?
|
| Travel | 1 | 2020 | 785 | 0.120 |
Why?
|
| Cues | 1 | 1999 | 867 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 3604 | 0.120 |
Why?
|
| Human Rights | 1 | 1997 | 306 | 0.120 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2000 | 592 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 2006 | 430 | 0.120 |
Why?
|
| Mutation | 8 | 2022 | 29932 | 0.110 |
Why?
|
| Sensory Gating | 1 | 2014 | 47 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2015 | 4048 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 13 | 3 | 2006 | 193 | 0.110 |
Why?
|
| Adaptation, Psychological | 4 | 2015 | 2628 | 0.110 |
Why?
|
| New England | 5 | 2019 | 1050 | 0.110 |
Why?
|
| Electroconvulsive Therapy | 6 | 1982 | 502 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2010 | 1313 | 0.110 |
Why?
|
| Apolipoproteins E | 3 | 2022 | 1436 | 0.110 |
Why?
|
| Quality of Life | 8 | 2015 | 13308 | 0.110 |
Why?
|
| Genetics, Behavioral | 2 | 2012 | 53 | 0.110 |
Why?
|
| Medical Record Linkage | 2 | 2001 | 288 | 0.110 |
Why?
|
| Lithium | 6 | 1981 | 596 | 0.110 |
Why?
|
| Logic | 1 | 2013 | 42 | 0.110 |
Why?
|
| Mental Competency | 1 | 2014 | 175 | 0.110 |
Why?
|
| Carrier Proteins | 4 | 2018 | 4938 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2002 | 1084 | 0.110 |
Why?
|
| Austria | 2 | 2003 | 206 | 0.110 |
Why?
|
| Sex Differentiation | 1 | 2013 | 73 | 0.110 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2005 | 361 | 0.110 |
Why?
|
| Nervous System Diseases | 2 | 2002 | 1647 | 0.110 |
Why?
|
| Blood Proteins | 1 | 2018 | 1173 | 0.110 |
Why?
|
| Aging | 9 | 2014 | 8651 | 0.100 |
Why?
|
| Maternal Behavior | 1 | 1995 | 306 | 0.100 |
Why?
|
| Dyslipidemias | 2 | 2018 | 895 | 0.100 |
Why?
|
| Neural Pathways | 5 | 2019 | 3040 | 0.100 |
Why?
|
| Apolipoprotein E4 | 2 | 2022 | 707 | 0.100 |
Why?
|
| Pharmacogenetics | 2 | 2007 | 680 | 0.100 |
Why?
|
| Puberty | 1 | 2016 | 498 | 0.100 |
Why?
|
| Cognitive Reserve | 1 | 2013 | 92 | 0.100 |
Why?
|
| Marriage | 8 | 1991 | 350 | 0.100 |
Why?
|
| Autistic Disorder | 3 | 2011 | 1216 | 0.100 |
Why?
|
| Survival Analysis | 7 | 2017 | 10182 | 0.100 |
Why?
|
| Double-Blind Method | 8 | 2018 | 12427 | 0.100 |
Why?
|
| Sampling Studies | 1 | 1993 | 613 | 0.100 |
Why?
|
| Linear Models | 7 | 2020 | 5877 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2002 | 127 | 0.100 |
Why?
|
| CpG Islands | 3 | 2006 | 1221 | 0.100 |
Why?
|
| Cooperative Behavior | 3 | 2012 | 1500 | 0.100 |
Why?
|
| Introns | 3 | 2009 | 978 | 0.100 |
Why?
|
| Annexin A7 | 1 | 2011 | 2 | 0.100 |
Why?
|
| Chronic Disease | 10 | 2012 | 9287 | 0.100 |
Why?
|
| Perceptual Disorders | 2 | 2017 | 197 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2016 | 2913 | 0.100 |
Why?
|
| Flushing | 1 | 2011 | 52 | 0.090 |
Why?
|
| Cytokines | 5 | 2018 | 7343 | 0.090 |
Why?
|
| Bayes Theorem | 2 | 2017 | 2326 | 0.090 |
Why?
|
| Interviews as Topic | 4 | 2010 | 2659 | 0.090 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2011 | 81 | 0.090 |
Why?
|
| Object Attachment | 1 | 2014 | 324 | 0.090 |
Why?
|
| Fibromyalgia | 2 | 2008 | 401 | 0.090 |
Why?
|
| Feedback, Psychological | 1 | 2011 | 95 | 0.090 |
Why?
|
| Risk-Taking | 2 | 2015 | 998 | 0.090 |
Why?
|
| Patient Selection | 3 | 2020 | 4283 | 0.090 |
Why?
|
| Morphogenesis | 1 | 2014 | 740 | 0.090 |
Why?
|
| Retrospective Studies | 24 | 2023 | 80372 | 0.090 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2005 | 622 | 0.090 |
Why?
|
| Brain Diseases | 4 | 2011 | 1540 | 0.090 |
Why?
|
| Genetics, Population | 3 | 2019 | 930 | 0.090 |
Why?
|
| Remission, Spontaneous | 3 | 2018 | 384 | 0.090 |
Why?
|
| Receptor, trkB | 1 | 2011 | 125 | 0.090 |
Why?
|
| Time Factors | 15 | 2016 | 40165 | 0.090 |
Why?
|
| Niacin | 1 | 2011 | 119 | 0.090 |
Why?
|
| Forecasting | 5 | 2000 | 2932 | 0.090 |
Why?
|
| Receptors, Notch | 3 | 2005 | 743 | 0.090 |
Why?
|
| Research | 3 | 2008 | 1974 | 0.090 |
Why?
|
| Atrophy | 5 | 2014 | 1627 | 0.090 |
Why?
|
| Sequence Deletion | 2 | 2005 | 1493 | 0.090 |
Why?
|
| Affect | 5 | 2018 | 1480 | 0.090 |
Why?
|
| Antidepressive Agents, Tricyclic | 3 | 1982 | 432 | 0.090 |
Why?
|
| Arrestins | 1 | 2010 | 73 | 0.090 |
Why?
|
| Testosterone | 2 | 2011 | 2470 | 0.090 |
Why?
|
| Sample Size | 4 | 2016 | 840 | 0.090 |
Why?
|
| Sex Distribution | 3 | 2006 | 2295 | 0.090 |
Why?
|
| DNA | 5 | 2007 | 7233 | 0.090 |
Why?
|
| Sexual Behavior | 1 | 1999 | 2086 | 0.090 |
Why?
|
| Violence | 1 | 2016 | 927 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2017 | 3164 | 0.090 |
Why?
|
| ROC Curve | 4 | 2016 | 3568 | 0.090 |
Why?
|
| Lorazepam | 2 | 1990 | 154 | 0.080 |
Why?
|
| Self Report | 3 | 2017 | 3711 | 0.080 |
Why?
|
| Achievement | 2 | 2006 | 289 | 0.080 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2009 | 48 | 0.080 |
Why?
|
| Visual Perception | 3 | 2015 | 1374 | 0.080 |
Why?
|
| Infant, Newborn | 10 | 2011 | 26181 | 0.080 |
Why?
|
| Rhode Island | 1 | 2010 | 349 | 0.080 |
Why?
|
| Personality Tests | 2 | 2000 | 81 | 0.080 |
Why?
|
| Europe | 3 | 2003 | 3441 | 0.080 |
Why?
|
| Demography | 3 | 2006 | 1650 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 4573 | 0.080 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2013 | 284 | 0.080 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2012 | 599 | 0.080 |
Why?
|
| Likelihood Functions | 3 | 2017 | 987 | 0.080 |
Why?
|
| Antidepressive Agents | 4 | 2009 | 2890 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2018 | 1387 | 0.080 |
Why?
|
| Sensitivity and Specificity | 6 | 2018 | 14660 | 0.080 |
Why?
|
| Smoking Cessation | 4 | 2006 | 2064 | 0.080 |
Why?
|
| Receptors, Dopamine | 2 | 2004 | 292 | 0.080 |
Why?
|
| Breech Presentation | 1 | 1988 | 39 | 0.080 |
Why?
|
| Arousal | 5 | 2015 | 1157 | 0.080 |
Why?
|
| Infant | 12 | 2013 | 36060 | 0.080 |
Why?
|
| Binge-Eating Disorder | 1 | 2010 | 147 | 0.080 |
Why?
|
| Alzheimer Disease | 2 | 2022 | 8547 | 0.080 |
Why?
|
| Social Class | 7 | 2005 | 2005 | 0.080 |
Why?
|
| GTP-Binding Proteins | 2 | 2013 | 951 | 0.080 |
Why?
|
| Parietal Lobe | 3 | 2005 | 850 | 0.080 |
Why?
|
| Molecular Motor Proteins | 1 | 2008 | 105 | 0.080 |
Why?
|
| Weight Gain | 1 | 2018 | 2347 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 3765 | 0.070 |
Why?
|
| Nucleosomes | 1 | 2011 | 484 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 4 | 1998 | 791 | 0.070 |
Why?
|
| Boston | 5 | 2010 | 9280 | 0.070 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2007 | 32 | 0.070 |
Why?
|
| Existentialism | 1 | 2007 | 38 | 0.070 |
Why?
|
| Dagestan | 1 | 2006 | 1 | 0.070 |
Why?
|
| Monocytes | 1 | 2016 | 2575 | 0.070 |
Why?
|
| Ambulatory Care | 5 | 2006 | 2781 | 0.070 |
Why?
|
| Base Sequence | 3 | 2011 | 12446 | 0.070 |
Why?
|
| RNA, Messenger | 6 | 2013 | 12766 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 1135 | 0.070 |
Why?
|
| Overweight | 1 | 2018 | 2421 | 0.070 |
Why?
|
| Residence Characteristics | 7 | 2022 | 2062 | 0.070 |
Why?
|
| Employment | 6 | 2017 | 1112 | 0.070 |
Why?
|
| Behavior, Animal | 3 | 2011 | 1866 | 0.070 |
Why?
|
| Poverty | 1 | 2019 | 2695 | 0.070 |
Why?
|
| North Carolina | 1 | 2007 | 325 | 0.070 |
Why?
|
| Algorithms | 5 | 2017 | 13981 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2008 | 402 | 0.070 |
Why?
|
| Cross-Cultural Comparison | 2 | 2003 | 633 | 0.070 |
Why?
|
| Meta-Analysis as Topic | 2 | 2008 | 1376 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 1753 | 0.070 |
Why?
|
| Adolescent Behavior | 1 | 1995 | 1175 | 0.070 |
Why?
|
| Receptor, Notch2 | 1 | 2006 | 87 | 0.070 |
Why?
|
| Mortality | 6 | 1996 | 2916 | 0.070 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2010 | 568 | 0.070 |
Why?
|
| RGS Proteins | 1 | 2006 | 75 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1741 | 0.070 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2008 | 215 | 0.070 |
Why?
|
| Life Style | 3 | 2008 | 3896 | 0.070 |
Why?
|
| Sex Chromatin | 3 | 1975 | 19 | 0.070 |
Why?
|
| Religion and Medicine | 1 | 2007 | 160 | 0.060 |
Why?
|
| Environmental Exposure | 2 | 2003 | 4412 | 0.060 |
Why?
|
| Valine | 1 | 2007 | 409 | 0.060 |
Why?
|
| Neurotransmitter Agents | 3 | 2007 | 663 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 1827 | 0.060 |
Why?
|
| Fatigue | 1 | 2012 | 1544 | 0.060 |
Why?
|
| Social Security | 1 | 1985 | 101 | 0.060 |
Why?
|
| Psychology | 1 | 2007 | 355 | 0.060 |
Why?
|
| RNA | 2 | 2005 | 2722 | 0.060 |
Why?
|
| Drug Design | 2 | 2009 | 1061 | 0.060 |
Why?
|
| Methionine | 1 | 2007 | 569 | 0.060 |
Why?
|
| Animals | 17 | 2016 | 167963 | 0.060 |
Why?
|
| Phosphofructokinase-1 | 1 | 2004 | 51 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2009 | 10827 | 0.060 |
Why?
|
| Benzodiazepines | 2 | 2009 | 1131 | 0.060 |
Why?
|
| Birth Order | 4 | 1984 | 95 | 0.060 |
Why?
|
| Phosphofructokinase-2 | 1 | 2004 | 32 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2008 | 619 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2005 | 298 | 0.060 |
Why?
|
| Public Opinion | 1 | 2008 | 481 | 0.060 |
Why?
|
| Lentigo | 2 | 1982 | 37 | 0.060 |
Why?
|
| Schizophrenia, Catatonic | 5 | 1985 | 6 | 0.060 |
Why?
|
| Founder Effect | 1 | 2005 | 186 | 0.060 |
Why?
|
| Docosahexaenoic Acids | 1 | 2011 | 912 | 0.060 |
Why?
|
| Russia | 1 | 2005 | 381 | 0.060 |
Why?
|
| Serine | 1 | 2008 | 830 | 0.060 |
Why?
|
| Hypertension | 3 | 2018 | 8594 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2005 | 315 | 0.060 |
Why?
|
| HLA-DR Antigens | 1 | 2005 | 630 | 0.060 |
Why?
|
| Hexokinase | 1 | 2004 | 125 | 0.060 |
Why?
|
| Anisotropy | 2 | 2018 | 1278 | 0.060 |
Why?
|
| Dyslexia | 1 | 2005 | 208 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2011 | 2873 | 0.060 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2003 | 38 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2001 | 7475 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2012 | 2440 | 0.060 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 284 | 0.060 |
Why?
|
| Incidence | 5 | 2015 | 21392 | 0.050 |
Why?
|
| Maternal Deprivation | 1 | 1983 | 48 | 0.050 |
Why?
|
| Disease Models, Animal | 6 | 2012 | 18137 | 0.050 |
Why?
|
| Colonic Diseases, Functional | 1 | 2003 | 39 | 0.050 |
Why?
|
| Genetic Load | 1 | 2003 | 15 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3106 | 0.050 |
Why?
|
| Cysteine | 1 | 2008 | 895 | 0.050 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 324 | 0.050 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2002 | 28 | 0.050 |
Why?
|
| Migraine Disorders | 2 | 2008 | 1693 | 0.050 |
Why?
|
| Receptors, Serotonin | 1 | 2004 | 208 | 0.050 |
Why?
|
| Biometry | 1 | 2006 | 559 | 0.050 |
Why?
|
| Geography | 1 | 2005 | 661 | 0.050 |
Why?
|
| Psychotherapy | 2 | 2010 | 1640 | 0.050 |
Why?
|
| Phencyclidine | 2 | 2007 | 60 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2015 | 3047 | 0.050 |
Why?
|
| Random Allocation | 2 | 2002 | 2394 | 0.050 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2005 | 415 | 0.050 |
Why?
|
| Schizoid Personality Disorder | 2 | 1979 | 14 | 0.050 |
Why?
|
| Hospitalization | 11 | 2002 | 10790 | 0.050 |
Why?
|
| Cataplexy | 1 | 2003 | 61 | 0.050 |
Why?
|
| Models, Neurological | 2 | 2002 | 1758 | 0.050 |
Why?
|
| Pyruvate Kinase | 1 | 2004 | 190 | 0.050 |
Why?
|
| Serial Learning | 2 | 2008 | 41 | 0.050 |
Why?
|
| DNA Primers | 1 | 2007 | 2819 | 0.050 |
Why?
|
| Galvanic Skin Response | 1 | 2004 | 348 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 1 | 2011 | 1190 | 0.050 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2008 | 453 | 0.050 |
Why?
|
| Asia, Southeastern | 1 | 2002 | 113 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 4 | 2013 | 707 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2005 | 652 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 1983 | 198 | 0.050 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1982 | 155 | 0.050 |
Why?
|
| Dopamine Antagonists | 1 | 2002 | 288 | 0.050 |
Why?
|
| Ureteral Calculi | 1 | 1983 | 116 | 0.050 |
Why?
|
| Neuronal Plasticity | 2 | 2021 | 1430 | 0.050 |
Why?
|
| Recurrence | 6 | 2000 | 8482 | 0.050 |
Why?
|
| Observer Variation | 2 | 2006 | 2601 | 0.050 |
Why?
|
| False Positive Reactions | 2 | 1995 | 956 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 2448 | 0.050 |
Why?
|
| Seminal Vesicles | 1 | 1981 | 107 | 0.050 |
Why?
|
| Thiazoles | 1 | 2009 | 1511 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2005 | 1991 | 0.050 |
Why?
|
| Eugenics | 2 | 1997 | 17 | 0.050 |
Why?
|
| Data Collection | 4 | 2006 | 3315 | 0.050 |
Why?
|
| Neurotic Disorders | 5 | 1984 | 77 | 0.050 |
Why?
|
| Asia | 1 | 2003 | 620 | 0.050 |
Why?
|
| Rest | 2 | 2021 | 914 | 0.050 |
Why?
|
| History, 20th Century | 3 | 1997 | 2773 | 0.050 |
Why?
|
| Fluphenazine | 2 | 1991 | 35 | 0.050 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2001 | 303 | 0.050 |
Why?
|
| Histones | 1 | 2011 | 2583 | 0.050 |
Why?
|
| New Jersey | 4 | 2002 | 291 | 0.050 |
Why?
|
| Databases, Factual | 3 | 2008 | 8035 | 0.050 |
Why?
|
| Models, Biological | 6 | 2014 | 9467 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 6 | 1985 | 1913 | 0.050 |
Why?
|
| Brain Damage, Chronic | 2 | 1979 | 267 | 0.050 |
Why?
|
| Mathematics | 3 | 1995 | 707 | 0.050 |
Why?
|
| Reading | 3 | 2007 | 529 | 0.050 |
Why?
|
| Parent-Child Relations | 1 | 2005 | 758 | 0.040 |
Why?
|
| Postmortem Changes | 2 | 2012 | 119 | 0.040 |
Why?
|
| Insurance Claim Reporting | 1 | 2001 | 165 | 0.040 |
Why?
|
| Biological Psychiatry | 1 | 2000 | 26 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2009 | 1380 | 0.040 |
Why?
|
| Glutamate Decarboxylase | 1 | 2001 | 239 | 0.040 |
Why?
|
| Neuregulins | 1 | 2019 | 36 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 1992 | 2250 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2003 | 428 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 5889 | 0.040 |
Why?
|
| Proteome | 2 | 2016 | 1855 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2007 | 1248 | 0.040 |
Why?
|
| Speech Perception | 2 | 2014 | 505 | 0.040 |
Why?
|
| Personality Development | 2 | 1990 | 244 | 0.040 |
Why?
|
| Proportional Hazards Models | 6 | 2021 | 12531 | 0.040 |
Why?
|
| Disability Evaluation | 3 | 2017 | 1826 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 2101 | 0.040 |
Why?
|
| Accidents, Traffic | 1 | 1985 | 814 | 0.040 |
Why?
|
| Molecular Biology | 1 | 2003 | 580 | 0.040 |
Why?
|
| Clinical Trials as Topic | 3 | 2007 | 8056 | 0.040 |
Why?
|
| Maternal Welfare | 1 | 2000 | 112 | 0.040 |
Why?
|
| Acoustics | 1 | 2020 | 242 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 420 | 0.040 |
Why?
|
| Japan | 1 | 2003 | 1369 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 1988 | 1229 | 0.040 |
Why?
|
| Medical Records | 2 | 2000 | 1407 | 0.040 |
Why?
|
| Lymphotoxin-alpha | 1 | 2018 | 94 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2001 | 244 | 0.040 |
Why?
|
| Karyotyping | 4 | 2011 | 1171 | 0.040 |
Why?
|
| Connexins | 1 | 2020 | 351 | 0.040 |
Why?
|
| Signal Detection, Psychological | 1 | 1998 | 84 | 0.040 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 1979 | 99 | 0.040 |
Why?
|
| Prediabetic State | 2 | 2018 | 550 | 0.040 |
Why?
|
| Evoked Potentials, Visual | 1 | 2021 | 415 | 0.040 |
Why?
|
| Family Therapy | 1 | 2020 | 213 | 0.040 |
Why?
|
| Hospital Records | 2 | 1991 | 93 | 0.040 |
Why?
|
| Piperazines | 1 | 2009 | 2525 | 0.040 |
Why?
|
| Hospitals, Psychiatric | 2 | 1997 | 320 | 0.040 |
Why?
|
| Dysthymic Disorder | 1 | 1998 | 75 | 0.040 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 1979 | 195 | 0.040 |
Why?
|
| Prehypertension | 1 | 2018 | 63 | 0.040 |
Why?
|
| Juvenile Delinquency | 2 | 1993 | 116 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2001 | 979 | 0.040 |
Why?
|
| Neurons | 3 | 2012 | 9426 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2018 | 151 | 0.040 |
Why?
|
| Hospitals, Veterans | 1 | 2000 | 398 | 0.040 |
Why?
|
| Mice | 9 | 2011 | 81208 | 0.040 |
Why?
|
| Superior Sagittal Sinus | 1 | 2017 | 15 | 0.040 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2018 | 193 | 0.040 |
Why?
|
| Chromosomes | 3 | 2010 | 575 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 1999 | 373 | 0.040 |
Why?
|
| Preventive Health Services | 1 | 2002 | 570 | 0.040 |
Why?
|
| Codes of Ethics | 1 | 1997 | 61 | 0.040 |
Why?
|
| Biomedical Research | 2 | 2012 | 3426 | 0.040 |
Why?
|
| Age Distribution | 1 | 2003 | 2893 | 0.040 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2018 | 278 | 0.040 |
Why?
|
| State Government | 1 | 2000 | 380 | 0.040 |
Why?
|
| Observation | 1 | 1999 | 312 | 0.040 |
Why?
|
| Radiography | 4 | 2013 | 6965 | 0.040 |
Why?
|
| Family Relations | 1 | 1999 | 318 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 678 | 0.040 |
Why?
|
| Contingent Negative Variation | 1 | 2017 | 36 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2011 | 17624 | 0.040 |
Why?
|
| National Socialism | 1 | 1997 | 54 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2002 | 1067 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 893 | 0.030 |
Why?
|
| Prolactin | 2 | 2002 | 621 | 0.030 |
Why?
|
| Sex Chromosomes | 2 | 2013 | 101 | 0.030 |
Why?
|
| Computers | 2 | 2015 | 595 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2001 | 1529 | 0.030 |
Why?
|
| Socialization | 1 | 1996 | 86 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 1981 | 20509 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2005 | 4122 | 0.030 |
Why?
|
| Choline | 1 | 2018 | 513 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 2018 | 177 | 0.030 |
Why?
|
| Criminal Psychology | 1 | 1995 | 15 | 0.030 |
Why?
|
| Paranoid Personality Disorder | 1 | 1995 | 7 | 0.030 |
Why?
|
| Temperament | 1 | 1998 | 295 | 0.030 |
Why?
|
| Language Tests | 2 | 2006 | 190 | 0.030 |
Why?
|
| Problem Solving | 2 | 2008 | 440 | 0.030 |
Why?
|
| Diabetes Insipidus | 1 | 1976 | 144 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2000 | 579 | 0.030 |
Why?
|
| Friends | 1 | 2017 | 150 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 1980 | 1975 | 0.030 |
Why?
|
| Exercise | 1 | 2012 | 5787 | 0.030 |
Why?
|
| Euphoria | 1 | 1975 | 65 | 0.030 |
Why?
|
| Motivation | 2 | 2001 | 1993 | 0.030 |
Why?
|
| Monoamine Oxidase | 1 | 1996 | 178 | 0.030 |
Why?
|
| Eye Movement Measurements | 1 | 2014 | 31 | 0.030 |
Why?
|
| Paired-Associate Learning | 1 | 1995 | 53 | 0.030 |
Why?
|
| X Chromosome | 2 | 1990 | 815 | 0.030 |
Why?
|
| Seasons | 2 | 1992 | 1522 | 0.030 |
Why?
|
| Klinefelter Syndrome | 1 | 1975 | 47 | 0.030 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2024 | 1079 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 2221 | 0.030 |
Why?
|
| Aged, 80 and over | 8 | 2012 | 58995 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2018 | 632 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2001 | 1077 | 0.030 |
Why?
|
| Schools | 1 | 2023 | 1480 | 0.030 |
Why?
|
| Telephone | 1 | 1998 | 624 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 1981 | 1186 | 0.030 |
Why?
|
| Mass Screening | 3 | 2001 | 5423 | 0.030 |
Why?
|
| Models, Animal | 1 | 2001 | 2117 | 0.030 |
Why?
|
| Pleasure | 1 | 2014 | 40 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2006 | 508 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2018 | 12103 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 212 | 0.030 |
Why?
|
| Underachievement | 1 | 1993 | 15 | 0.030 |
Why?
|
| Skull | 1 | 1978 | 815 | 0.030 |
Why?
|
| Heart Diseases | 2 | 2006 | 2809 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 4713 | 0.030 |
Why?
|
| Confidentiality | 1 | 1998 | 609 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 2907 | 0.030 |
Why?
|
| Breast Neoplasms | 4 | 2002 | 21025 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 1067 | 0.030 |
Why?
|
| Life Tables | 1 | 1994 | 365 | 0.030 |
Why?
|
| Dichotic Listening Tests | 1 | 1993 | 22 | 0.030 |
Why?
|
| Myelin Sheath | 2 | 2008 | 652 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 747 | 0.030 |
Why?
|
| Education, Special | 1 | 1993 | 86 | 0.030 |
Why?
|
| Cephalometry | 1 | 1995 | 382 | 0.030 |
Why?
|
| Kinetics | 6 | 1986 | 6377 | 0.030 |
Why?
|
| Prejudice | 1 | 1997 | 563 | 0.030 |
Why?
|
| Intramolecular Transferases | 1 | 2012 | 15 | 0.030 |
Why?
|
| Afghan Campaign 2001- | 1 | 2014 | 296 | 0.030 |
Why?
|
| Hallucinogens | 1 | 1996 | 194 | 0.030 |
Why?
|
| Anger | 1 | 1975 | 401 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 2210 | 0.030 |
Why?
|
| Medicaid | 3 | 2001 | 2815 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 1979 | 763 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 3 | 1980 | 1628 | 0.030 |
Why?
|
| Proteins | 1 | 2007 | 6029 | 0.030 |
Why?
|
| Prostatectomy | 1 | 1981 | 1956 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1995 | 499 | 0.030 |
Why?
|
| Brain Edema | 1 | 2017 | 603 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2018 | 3215 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 10344 | 0.030 |
Why?
|
| Sex Ratio | 2 | 1987 | 107 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2010 | 1132 | 0.030 |
Why?
|
| Catecholamines | 1 | 1993 | 385 | 0.030 |
Why?
|
| Eye Movements | 1 | 1995 | 508 | 0.030 |
Why?
|
| Half-Life | 4 | 1986 | 652 | 0.020 |
Why?
|
| Maternal Age | 2 | 1983 | 807 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1981 | 1869 | 0.020 |
Why?
|
| Behavior | 2 | 2008 | 540 | 0.020 |
Why?
|
| Drug Therapy, Combination | 3 | 1997 | 6498 | 0.020 |
Why?
|
| Thioridazine | 1 | 1971 | 33 | 0.020 |
Why?
|
| Confusion | 2 | 2005 | 279 | 0.020 |
Why?
|
| Mosaicism | 1 | 1975 | 466 | 0.020 |
Why?
|
| Orientation | 2 | 2006 | 321 | 0.020 |
Why?
|
| Metagenome | 1 | 2015 | 450 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2002 | 2733 | 0.020 |
Why?
|
| Information Systems | 1 | 1993 | 398 | 0.020 |
Why?
|
| DNA Probes | 1 | 2012 | 551 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2011 | 159 | 0.020 |
Why?
|
| Scalp | 1 | 1974 | 389 | 0.020 |
Why?
|
| Disabled Persons | 1 | 2001 | 1223 | 0.020 |
Why?
|
| Glucose | 1 | 2003 | 4351 | 0.020 |
Why?
|
| Brain Injuries | 2 | 2001 | 2044 | 0.020 |
Why?
|
| Referral and Consultation | 2 | 2012 | 3598 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2016 | 619 | 0.020 |
Why?
|
| Mucopolysaccharidoses | 1 | 1970 | 27 | 0.020 |
Why?
|
| Genes, Dominant | 3 | 1982 | 863 | 0.020 |
Why?
|
| Public Health | 1 | 2004 | 2653 | 0.020 |
Why?
|
| Language Development Disorders | 1 | 2012 | 192 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2018 | 2208 | 0.020 |
Why?
|
| Arabidopsis Proteins | 1 | 2012 | 263 | 0.020 |
Why?
|
| Independent Living | 1 | 2015 | 570 | 0.020 |
Why?
|
| Mental Health Services | 1 | 2002 | 1717 | 0.020 |
Why?
|
| Prescriptions | 1 | 2013 | 388 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2015 | 915 | 0.020 |
Why?
|
| California | 1 | 2014 | 1416 | 0.020 |
Why?
|
| Social Isolation | 1 | 1993 | 362 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 9585 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2011 | 313 | 0.020 |
Why?
|
| Homozygote | 1 | 2015 | 1788 | 0.020 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2010 | 34 | 0.020 |
Why?
|
| Somatoform Disorders | 1 | 1993 | 423 | 0.020 |
Why?
|
| Guilt | 1 | 1990 | 96 | 0.020 |
Why?
|
| Schools, Medical | 1 | 1997 | 878 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 1991 | 553 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 3340 | 0.020 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2010 | 100 | 0.020 |
Why?
|
| Publishing | 1 | 1997 | 836 | 0.020 |
Why?
|
| Brain Concussion | 1 | 1981 | 1394 | 0.020 |
Why?
|
| Genetic Pleiotropy | 1 | 2011 | 181 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2010 | 198 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2001 | 4541 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 866 | 0.020 |
Why?
|
| Individuality | 1 | 2011 | 300 | 0.020 |
Why?
|
| Viremia | 1 | 1992 | 707 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 1974 | 704 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1990 | 410 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 1992 | 916 | 0.020 |
Why?
|
| Health Services Research | 1 | 1996 | 1810 | 0.020 |
Why?
|
| Skin Tests | 1 | 2011 | 637 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2009 | 58 | 0.020 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1989 | 165 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1995 | 1764 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 350 | 0.020 |
Why?
|
| Internal-External Control | 1 | 2010 | 359 | 0.020 |
Why?
|
| Tai Ji | 1 | 2012 | 287 | 0.020 |
Why?
|
| Acridines | 1 | 1968 | 19 | 0.020 |
Why?
|
| Computer Simulation | 2 | 1993 | 6218 | 0.020 |
Why?
|
| Aggression | 1 | 1993 | 745 | 0.020 |
Why?
|
| Canada | 1 | 2014 | 2128 | 0.020 |
Why?
|
| Heterozygote | 1 | 2015 | 2798 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 1996 | 1178 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 2802 | 0.020 |
Why?
|
| Chlorpromazine | 1 | 1968 | 111 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2010 | 6544 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 562 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 16939 | 0.020 |
Why?
|
| Tranquilizing Agents | 1 | 1968 | 58 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2015 | 2194 | 0.020 |
Why?
|
| Motor Cortex | 1 | 2015 | 995 | 0.020 |
Why?
|
| Microglia | 1 | 2017 | 1351 | 0.020 |
Why?
|
| Fathers | 1 | 2011 | 376 | 0.020 |
Why?
|
| Heart Failure | 1 | 2012 | 11847 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 310 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 1991 | 961 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1974 | 3105 | 0.020 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2009 | 207 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2010 | 454 | 0.020 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2007 | 59 | 0.020 |
Why?
|
| Occupations | 2 | 1979 | 515 | 0.020 |
Why?
|
| Child Development | 1 | 1999 | 2285 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 9530 | 0.020 |
Why?
|
| Tyrosine | 1 | 2011 | 1438 | 0.020 |
Why?
|
| Quality Control | 1 | 2009 | 828 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2010 | 772 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 1894 | 0.020 |
Why?
|
| Video Games | 1 | 2008 | 190 | 0.020 |
Why?
|
| Signal Transduction | 4 | 2011 | 23376 | 0.020 |
Why?
|
| Down Syndrome | 2 | 1965 | 892 | 0.020 |
Why?
|
| Cell Division | 1 | 1974 | 4463 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2009 | 65017 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2011 | 1388 | 0.020 |
Why?
|
| Massachusetts | 2 | 2006 | 8803 | 0.020 |
Why?
|
| Body Mass Index | 3 | 2009 | 12914 | 0.020 |
Why?
|
| Color Perception | 1 | 2006 | 212 | 0.020 |
Why?
|
| Linguistics | 1 | 2006 | 106 | 0.020 |
Why?
|
| SEER Program | 2 | 2001 | 1530 | 0.020 |
Why?
|
| Desipramine | 1 | 1985 | 182 | 0.020 |
Why?
|
| Medicare | 2 | 2001 | 6786 | 0.020 |
Why?
|
| Activities of Daily Living | 2 | 1991 | 2417 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2012 | 1738 | 0.020 |
Why?
|
| Borderline Personality Disorder | 1 | 1992 | 765 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 293 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1977 | 2159 | 0.020 |
Why?
|
| Alcoholic Intoxication | 1 | 1985 | 174 | 0.010 |
Why?
|
| Paternal Deprivation | 1 | 1983 | 10 | 0.010 |
Why?
|
| Diet | 1 | 1982 | 8010 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 1989 | 1257 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2014 | 5201 | 0.010 |
Why?
|
| New York | 1 | 2006 | 875 | 0.010 |
Why?
|
| Gender Identity | 1 | 1989 | 698 | 0.010 |
Why?
|
| Obesity | 1 | 2006 | 12922 | 0.010 |
Why?
|
| Divorce | 1 | 1983 | 76 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2007 | 943 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1991 | 4035 | 0.010 |
Why?
|
| Prednisolone | 1 | 1984 | 327 | 0.010 |
Why?
|
| Intention | 1 | 2006 | 345 | 0.010 |
Why?
|
| Convulsive Therapy | 1 | 1982 | 3 | 0.010 |
Why?
|
| Drug Therapy | 1 | 2006 | 504 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 2013 | 0.010 |
Why?
|
| Cystoscopy | 1 | 1983 | 133 | 0.010 |
Why?
|
| Amoxapine | 1 | 1982 | 5 | 0.010 |
Why?
|
| Dibenzoxazepines | 1 | 1982 | 8 | 0.010 |
Why?
|
| Health Surveys | 1 | 2013 | 4063 | 0.010 |
Why?
|
| Tyramine | 1 | 1982 | 53 | 0.010 |
Why?
|
| Huntington Disease | 1 | 1969 | 1141 | 0.010 |
Why?
|
| Bender-Gestalt Test | 1 | 1981 | 3 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2011 | 2566 | 0.010 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 2002 | 61 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2006 | 699 | 0.010 |
Why?
|
| Hepatitis C | 1 | 1992 | 1579 | 0.010 |
Why?
|
| Epididymitis | 1 | 1981 | 37 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 2418 | 0.010 |
Why?
|
| Dementia | 2 | 1978 | 2649 | 0.010 |
Why?
|
| Snakes | 1 | 1981 | 29 | 0.010 |
Why?
|
| Theft | 1 | 1961 | 20 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2018 | 7850 | 0.010 |
Why?
|
| Sociology | 1 | 1961 | 21 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2007 | 1167 | 0.010 |
Why?
|
| Artifacts | 1 | 2010 | 1898 | 0.010 |
Why?
|
| Barbiturates | 1 | 1981 | 113 | 0.010 |
Why?
|
| Sleep Deprivation | 1 | 2008 | 840 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2007 | 1967 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 1889 | 0.010 |
Why?
|
| Enkephalins | 1 | 2001 | 139 | 0.010 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2001 | 108 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 1652 | 0.010 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2001 | 128 | 0.010 |
Why?
|
| Diazepam | 1 | 1981 | 215 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2008 | 1398 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 1902 | 0.010 |
Why?
|
| Trifluoperazine | 1 | 1980 | 37 | 0.010 |
Why?
|
| Ureter | 1 | 1983 | 375 | 0.010 |
Why?
|
| Amnesia | 1 | 1982 | 255 | 0.010 |
Why?
|
| Infant Behavior | 1 | 2001 | 154 | 0.010 |
Why?
|
| Perphenazine | 1 | 1999 | 33 | 0.010 |
Why?
|
| Prostatic Neoplasms | 2 | 1999 | 11345 | 0.010 |
Why?
|
| Imipramine | 1 | 1979 | 98 | 0.010 |
Why?
|
| Pirenzepine | 1 | 1999 | 116 | 0.010 |
Why?
|
| Hematoma, Subdural | 1 | 1980 | 126 | 0.010 |
Why?
|
| Hospitals, University | 1 | 1961 | 568 | 0.010 |
Why?
|
| Albumins | 1 | 2001 | 575 | 0.010 |
Why?
|
| Death | 1 | 1983 | 678 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2001 | 698 | 0.010 |
Why?
|
| Body Weight | 1 | 2009 | 4611 | 0.010 |
Why?
|
| Emigration and Immigration | 1 | 1961 | 395 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2001 | 1249 | 0.010 |
Why?
|
| Amobarbital | 1 | 1977 | 43 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1990 | 8552 | 0.010 |
Why?
|
| Accidents | 1 | 1978 | 166 | 0.010 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2002 | 919 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1982 | 1428 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 1980 | 351 | 0.010 |
Why?
|
| Neoplasms | 3 | 1983 | 22072 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1998 | 347 | 0.010 |
Why?
|
| Cause of Death | 1 | 1988 | 3725 | 0.010 |
Why?
|
| Consensus | 1 | 2007 | 3113 | 0.010 |
Why?
|
| Acute Disease | 2 | 1986 | 7269 | 0.010 |
Why?
|
| Benzothiadiazines | 1 | 1976 | 31 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2001 | 1134 | 0.010 |
Why?
|
| Models, Theoretical | 2 | 1987 | 3562 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 2648 | 0.010 |
Why?
|
| Anura | 1 | 1976 | 80 | 0.010 |
Why?
|
| Death, Sudden | 1 | 1978 | 302 | 0.010 |
Why?
|
| Electroshock | 1 | 1976 | 121 | 0.010 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 1976 | 78 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2006 | 1940 | 0.010 |
Why?
|
| Software | 1 | 2010 | 4419 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 14372 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5791 | 0.010 |
Why?
|
| Insurance Claim Review | 1 | 2000 | 738 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2001 | 1468 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 18957 | 0.010 |
Why?
|
| Child Behavior | 1 | 2001 | 847 | 0.010 |
Why?
|
| Cheek | 1 | 1975 | 65 | 0.010 |
Why?
|
| Vasopressins | 1 | 1976 | 355 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 1980 | 982 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 23711 | 0.010 |
Why?
|
| Obstetrical Forceps | 1 | 1974 | 8 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2001 | 1889 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1965 | 4090 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2009 | 6381 | 0.010 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1974 | 53 | 0.010 |
Why?
|
| Homovanillic Acid | 1 | 1993 | 75 | 0.010 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1993 | 93 | 0.010 |
Why?
|
| Tic Disorders | 1 | 1994 | 136 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2009 | 8525 | 0.010 |
Why?
|
| Diuretics | 1 | 1976 | 613 | 0.010 |
Why?
|
| Hypothalamic Diseases | 1 | 1974 | 134 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 1999 | 965 | 0.010 |
Why?
|
| Outpatients | 1 | 1961 | 1607 | 0.010 |
Why?
|
| Resorcinols | 1 | 1972 | 41 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2002 | 2634 | 0.010 |
Why?
|
| Culture Media | 1 | 1974 | 900 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 1993 | 274 | 0.010 |
Why?
|
| School Health Services | 1 | 1975 | 382 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1993 | 900 | 0.010 |
Why?
|
| Blood Donors | 1 | 1992 | 343 | 0.010 |
Why?
|
| Serologic Tests | 1 | 1992 | 383 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 4357 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2001 | 3143 | 0.010 |
Why?
|
| Psychopathology | 1 | 1993 | 429 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 1976 | 1166 | 0.010 |
Why?
|
| Strabismus | 1 | 1974 | 317 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 1972 | 426 | 0.010 |
Why?
|
| Cell Count | 1 | 1974 | 1835 | 0.010 |
Why?
|
| Cerebral Palsy | 1 | 1974 | 471 | 0.010 |
Why?
|
| Length of Stay | 1 | 1983 | 6479 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1999 | 2688 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 22023 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1972 | 1089 | 0.000 |
Why?
|
| Cattle | 1 | 1974 | 3847 | 0.000 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1983 | 3763 | 0.000 |
Why?
|
| Sex | 1 | 1967 | 52 | 0.000 |
Why?
|
| Retinitis Pigmentosa | 1 | 1970 | 397 | 0.000 |
Why?
|
| Dopamine | 1 | 1993 | 1595 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 12293 | 0.000 |
Why?
|
| HIV Infections | 1 | 1992 | 17165 | 0.000 |
Why?
|
| Diphenhydramine | 1 | 1985 | 63 | 0.000 |
Why?
|
| Cardiovascular Diseases | 2 | 1983 | 15757 | 0.000 |
Why?
|
| Hepacivirus | 1 | 1992 | 1334 | 0.000 |
Why?
|
| HIV | 1 | 1992 | 1579 | 0.000 |
Why?
|
| Hepatitis, Chronic | 1 | 1984 | 52 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1972 | 2611 | 0.000 |
Why?
|
| Minicomputers | 1 | 1983 | 10 | 0.000 |
Why?
|
| Chlordiazepoxide | 1 | 1963 | 42 | 0.000 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1985 | 285 | 0.000 |
Why?
|
| Visually Impaired Persons | 1 | 1963 | 78 | 0.000 |
Why?
|
| Metabolic Clearance Rate | 1 | 1981 | 361 | 0.000 |
Why?
|
| Blood Gas Analysis | 1 | 1982 | 379 | 0.000 |
Why?
|
| Lithium Carbonate | 1 | 1981 | 179 | 0.000 |
Why?
|
| Nephrotic Syndrome | 1 | 1984 | 391 | 0.000 |
Why?
|
| Drug Tolerance | 1 | 1981 | 369 | 0.000 |
Why?
|
| Cell Line | 1 | 1974 | 15620 | 0.000 |
Why?
|
| Placebos | 1 | 1963 | 1668 | 0.000 |
Why?
|
| Blindness | 1 | 1982 | 582 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1971 | 6414 | 0.000 |
Why?
|
| Hysteria | 1 | 1977 | 20 | 0.000 |
Why?
|
| Creatinine | 1 | 1981 | 1903 | 0.000 |
Why?
|
| Phenothiazines | 1 | 1975 | 61 | 0.000 |
Why?
|
| Psychological Theory | 1 | 1975 | 175 | 0.000 |
Why?
|
| Social Problems | 1 | 1974 | 109 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1981 | 4899 | 0.000 |
Why?
|
| Methods | 1 | 1973 | 1074 | 0.000 |
Why?
|
| Infant Mortality | 1 | 1978 | 757 | 0.000 |
Why?
|
| Writing | 1 | 1974 | 199 | 0.000 |
Why?
|
| Cytodiagnosis | 1 | 1973 | 442 | 0.000 |
Why?
|
| Seizures | 1 | 1982 | 2917 | 0.000 |
Why?
|